![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 471/08 | |
A61K 31/439 | |||
A61P 31/04 | |||
A61K 45/06 | |||
A61K 31/407 | |||
A61K 31/436 | |||
A61K 31/427 | |||
A61K 31/545 | |||
A61K 31/546 |
(11) | Number of the document | 2831075 |
(13) | Kind of document | T |
(96) | European patent application number | 13769724.9 |
Date of filing the European patent application | 2013-03-29 | |
(97) | Date of publication of the European application | 2015-02-04 |
(45) | Date of publication and mention of the grant of the patent | 2017-11-08 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2013/034562 |
Date | 2013-03-29 |
(87) | Number | WO 2013/149121 |
Date | 2013-10-03 |
(30) | Number | Date | Country code |
201261618131 P | 2012-03-30 | US | |
201361790579 P | 2013-03-15 | US |
(72) |
GU, Yu, Gui, US
HE, Yong, US
YIN, Ning, US
ALEXANDER, Dylan, C., US
CROSS, Jason, B., US
METCALF, Chester, A. III, US
BUSCH, Robert, US
|
(73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065,
US
|
(54) | 1,3,4-OXADIAZOLE AND 1,3,4-THIADIAZOLE BETA-LACTAMASE INHIBITORS |
1,3,4-OXADIAZOLE AND 1,3,4-THIADIAZOLE BETA-LACTAMASE INHIBITORS |